| Kimberly Lou Eddy, MA | |
|
2650 Jones Way Ste 10, Simi Valley, CA 93065-1215 | |
| (805) 522-1844 | |
| (805) 522-5345 |
| Full Name | Kimberly Lou Eddy |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 2650 Jones Way Ste 10, Simi Valley, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265600597 | NPI | - | NPPES |
| 25043 | Other | CA | PSYCHOLOGIST |
| 25043 | Other | CA | CA BOARD OF PSYCHOLOGY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 25043 (California) | Secondary |
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Lou Eddy, MA 8850 Penfield Ave, Northridge, CA 91324-3226 Ph: () - | Kimberly Lou Eddy, MA 2650 Jones Way Ste 10, Simi Valley, CA 93065-1215 Ph: (805) 522-1844 |
News Archive
A new discovery raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought. In a new study appearing online in The FASEB Journal, scientists have identified a way to detect the disorder using blood and have discovered that drugs which affect the methylation state of genes could reverse autism's effects.
Communicating effectively during an outbreak can be tricky for government agencies charged with protecting the public, according to Glen Nowak, former director of media relations at the Centers for Disease Control and Prevention and professor of advertising and public relations at the University of Georgia's Grady College of Journalism and Mass Communication.
The spread of the coronavirus disease (COVID-19) has reached pandemic status, spanning 114 countries and territories, the World Health Organization (WHO) declared. The novel coronavirus that emerged three months ago has rapidly infected more than 126,000 people, taking the lives of more than 4,600.
Researchers from Isis Pharmaceuticals (Carlsbad, CA) and Prysis Biotechnologies (Pudong, Shanghai, China) have demonstrated proof-of-concept for using a sense oligonucleotide to undo the effects of an antisense drug, an antithrombotic agent in this novel study.
A University of Warwick study to understand a form of epilepsy that affects children has received a grant from the charity Epilepsy Research UK. The research focuses on absence epilepsy which is largely a childhood condition which is characterized by sudden, brief interruptions of consciousness.
› Verified 9 days ago